| | Gilead Sciences Inc said on Tuesday it will partner with privately held insitro to develop therapies for a fatty liver disease called non-alcoholic steatohepatitis (NASH), as the drugmaker tries to overcome its recent setback in developing NASH treatments. | | | The Kenyan capital has experienced a jump in cholera cases, one of the city's top hospitals said on Tuesday, adding that eight of its own staff had been infected by the disease. | | | China will allow large-scale pig farms and breeding farms to test for African swine fever in a bid to help early detection of the disease, overturning an earlier prohibition on commercial firms carrying out their own testing. | | | The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent in the week ended April 11, in the country's second-worst outbreak in nearly two decades, federal health officials reported on Monday. | | | (Reuters Health) - Older adults who are victims of financial scams may be more likely to develop dementia and Alzheimer's disease than elderly people who don't get tricked by scammers, a small U.S. study suggests. | | | (Reuters Health) - The Food and Drug Administration's new mandatory rules requiring labels on all packaged foods and drinks to indicate the presence of so-called added sugars could have substantial health and cost saving benefits in the United States over the next two decades, a new study suggests. | | | (Reuters Health) - Over a typical 24-hour shift, first year residents training in internal medicine spend just three hours on direct patient care and only 1.8 hours on education, a U.S. study suggests. | | | Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12-month course of injections. | | | (Reuters Health) - People who regularly use cannabis may need more than twice the usual dose of anesthesia for surgery, a U.S. study suggests. | | | Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion in cash, bolstering its capabilities to make gene therapy drugs for its biotech clients. | | | The number of measles cases worldwide nearly quadrupled in the first quarter of 2019 to 112,163 against the same period last year, the World Health Organization (WHO) said on Monday, citing provisional data. | | | | |